Skip to main content
Oxford University Press - PMC COVID-19 Collection logoLink to Oxford University Press - PMC COVID-19 Collection
letter
. 2020 Jul 28:afaa176. doi: 10.1093/ageing/afaa176

Phosphate metabolism and respiratory alkalosis: a forgotten lesson in COVID-19

Timothy Seers 1,, Rebecca Davenport 1
PMCID: PMC7454253  PMID: 32725143

Sir,

Electrolyte abnormalities are common in frail older adults presenting to hospital, and are independently associated with mortality [1]. Phosphate homeostasis is crucial for not only bone mineralisation, but also cellular signalling and metabolism [2]. Hypophosphatemia and hypokalaemia are the primary electrolyte abnormalities associated with the ‘refeeding syndrome’ and this is a common clinical problem in older adults. Whilst the anabolic drive of phosphate intracellularly is well described in refeeding syndrome [2], it is important to remember other causes of deranged phosphate that may be seen in older adults.

Malabsorption and increased losses from either the gastrointestinal tract or renally are common causes of hypophosphatemia; however, other causes are often overlooked. Importantly, hyperventilation (in mechanically ventilated or spontaneously breathing patients) leads to a respiratory alkalosis and corresponding increase in intracellular pH [2]. This subsequently leads to increased phosphofructokinase activity and glycolysis in general, resulting in increased demand for phosphate intracellularly and a corresponding fall in extracellular phosphate [3].

This is an important mechanism to remember in the current COVID-19 pandemic, which has seen health services worldwide placed under strain with very large numbers of patients presenting with respiratory failure—many of whom are older, co-morbid, adults [4]. Many patients with COVID-19 will experience a period of compensatory hyperventilation and associated respiratory alkalosis prior to decompensation and subsequent respiratory failure [5]. Whilst, hypophosphatemia will frequently be multifactorial in this population, it is important for the geriatrician to remember that some hypophosphatemia may be explained by respiratory disease and may correct with improving respiratory function. This is especially important considering the burden of polypharmacy already faced by this population and recent concerns over the availability of some phosphate preparations commonly used in hospital.

Declaration of Conflicts of Interest

None.

References

  • 1. Sumukadas D, Jenkinson F, Witham MD. Associations and consequences of hypophosphataemia in older hospitalised women. Age Ageing 2009; 38: 112–4. [DOI] [PubMed] [Google Scholar]
  • 2. Wadsworth R, Siddiqui S. Phosphate homeostasis in critical care. BJA Educ 2016; 16: 305–9. [Google Scholar]
  • 3. Datta BN, Stone MD. Hyperventilation and hypophosphataemia. Ann Clin Biochem 2009; 46: 170–1. [DOI] [PubMed] [Google Scholar]
  • 4. Docherty AB, Harrison EM, Green CA et al. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO clinical characterisation protocol: prospective observational cohort study. BMJ 2020; 369. doi: 10.1136/bmj.m1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Ottestad W, Søvik S. COVID-19 patients with respiratory failure: what can we learn from aviation medicine? Br J Anaesth 2020. doi: 10.1016/j.bja.2020.04.012. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Age and Ageing are provided here courtesy of Oxford University Press

RESOURCES